Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming

Acta Oncologica

Volumn 49, Issue 1, 2010, Pages 76-84

  He, Qian ^a   Zhang, Shu Qun ^a   Chu, Yong Lie ^a   Jia, Xiao Li ^a   Zhao, Li Hua ^a   Wang, Xiang Ling ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; LAMIN A; LAMIN C; NUCLEAR MATRIX PROTEIN; PROHIBITIN;

ARTICLE; BIOINFORMATICS; BREAST CARCINOMA; BREAST HYPERPLASIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REPRODUCIBILITY; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PRECANCEROUS CONDITIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 76649119119     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903287213     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71- 96.
2. Pederson T Thinking about a nuclear matrix. J Mol Biol 1998; 277:147- 59.
3. Oge O, Atsü N, Kendi S, Ozen H. Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer. Int Urol Nephrol 2001; 32:367- 70.
4. Yoon GS, Lee H, Jung Y, Yu E, Moon HB, Song K, et al. Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res 2000; 60:1117- 20.
5. Brünagel G, Vietmeier BN, Bauer AJ, Schoen RE, Getzenberg RH. Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res 2002; 62:2437- 42.
6. Lakshmanan Y, Subong EN, Partin AW. Differential nuclear matrix protein expression in prostate cancers: Correlation with pathologic stage. J Urol 1998; 159:1354- 8.
7. Spencer VA, Samuel SK, Davie JR. Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines. Cancer Res 2000; 60:288- 92.
8. Spencer VA, Samuel SK, Davie JR. Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells. Cancer Res 2001; 61:1362- 6.
9. Michishita E, Kurahashi T, Suzuki T, Fukuda M, Fujii M, Hirano H, et al. Changes in nuclear matrix proteins during the senescence-like phenomenon induced by 5-chlorodeoxyuridine in HeLa cells. Exp Gerontol 2002; 37:885- 90.
10. Somasekhar MB, Gorski J. An estrogen-responsive element from the 5'-fl anking region of the rat prolactin gene functions in MCF-7 but not in HeLa cells. Gene 1988; 69:23- 8.
11. Fernandes DJ, Qiu J, Catapano CV. DNA topoisomerase II isozymes involved in anticancer drug action and resistance. Adv Enzyme Regul 1995; 35:265- 81.
12. Balajee AS, May A, Bohr V A. Fine structural analysis of DNA repair in mammalian cells. Mutat Res 1998; 404:3-11.
13. Xiong X D, Li EM, Xu L Y, Chen HB, Chen L, Cai WJ, et al. Separation and identifi cation of differentially expressed nuclear matrix proteins between human esophageal immortalized and carcinomatous cell lines. World J Gastroenterol 2003; 9:2143-8.
14. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profi ling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6.
15. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profi les to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365:671-9.
16. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P A, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
17. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, et al. Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 1993; 53:3394-8.
18. Love S, King RJ. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br J Cancer 1994; 69:743-8.
19. Arts HJ, Hollema H, Lemstra W, Willemse PH, De Vries EG, Kampinga HH, et al. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis. Int J Cancer 1999; 84:234-8.
20. O'Callaghan-Sunol C, Gabai VL, Sherman MY. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 2007; 67:11779-88.
21. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998; 79:468-75.
22. Dixit VD, Sridaran R, Edmonsond MA, Taub D, Thompson WE. Gonadotropin-releasing hormone attenuates pregnancy-associated thymic involution and modulates the expression of antiproliferative gene product prohibitin. Endocrinology 2003; 144:1496-505.
23. Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK. Chemoresistance in human ovarian cancer: The role of apoptotic regulators. Reprod Biol Endocrinol 2003; 1:66.
24. Coates PJ, Nenutil R, McGregor A, Picksley SM, Crouch DH, Hall PA, et al. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res 2001; 265:262-73.
25. Fusaro G, Wang S, Chellappan S. Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis. Oncogene 2002; 21:4539-48.
26. Chowdhur y I, Xu W, Stiles JK, Zeleznik A, Yao X, Matthews R, et al. Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin. Endocrinology 2007; 148:206-17.
27. Kurzeder C, Sauer G, Deissler H. Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy. Curr Cancer Drug Targets. 2006; 6:207-27.
28. Wydner KL, McNeil JA, Lin F, Worman HJ, Lawrence JB. Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. Genomics 1996; 32:474-8.
29. Moss SF, Krivosheyev V, de Souza A, Chin K, Gaetz HP, Chaudhary N, et al. Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 1999; 45:723-9.